Letter to the Editor: Quality testing of mifepristone and misoprostol in 11 countries
International Journal of Gynecology & Obstetrics · 2024
DOI: 10.1002/ijgo.15352 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Poppy Sullivan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Barts and the London, School of Medicine and Dentistry (QMUL), London, UK. Hauptthemen laut MEDLINE: Misoprostol, Abortifacient Agents, Abortion, Induced, Abortifacient Agents, Nonsteroidal. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Barts and the London, School of Medicine and Dentistry (QMUL), London, UK.
ORCID-Profile: Poppy Sullivan, Sabthagi Sivathasan
Zitieren
APA
Sullivan, P., & Sivathasan, S. (2024). Letter to the Editor: Quality testing of mifepristone and misoprostol in 11 countries. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15352
Vancouver
Sullivan P, Sivathasan S. Letter to the Editor: Quality testing of mifepristone and misoprostol in 11 countries. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.15352
BibTeX
@article{Sullivan2024,
author = {Sullivan, Poppy and Sivathasan, Sabthagi},
title = {Letter to the Editor: Quality testing of mifepristone and misoprostol in 11 countries},
journal = {International Journal of Gynecology & Obstetrics},
year = {2024},
doi = {10.1002/ijgo.15352}
}
EUVIMED